5/30/2023 0 Comments Element 118In conclusion, we developed a cell‐based luminescence assay to identify novel inhibitors targeting c‐MYC transcriptional activation, and have found five compounds that may function as lead compounds for further development. Key facts of the Periodic Table of 118 elements and their symbols Chemical elements are arranged in increasing atomic numbers. In the Modern Periodic table, there are 7 rows, called as periods or series, and 18 columns, known as groups. All five compounds demonstrate a significant ability to kill cancer cells in the nanomolar range. In this table, there is a total of 118 known chemical elements. Since the names of the elements can be long and complex to use, these are denoted using a symbol. The modern periodic table, today, consists of 118 elements in total. Elements are recognized using chemical symbols and formulae. 118 Elements List And Their Symbols And Atomic Numbers PDF Free Download. Elements can occur in all three states in the matter, that is, solid, liquid or gaseous state. Using a two‐step method for validation, we identified two candidate compounds from the DNA‐PKcs assay and three from the MK2 assay. There are 118 elements that exist in total till now, 94 elements out of these occur in nature whereas the 24 left are prepared artificially. Using custom antibodies specific for pOCT4 S93 and pOCT4 S111, the “hits” were validated for their effect on OCT4 phosphorylation and activation. After screening approximately 80,000 compounds, we identified 56 compounds (“hits”) that inhibited the luminescence reaction between DNA‐PKcs and OCT4, and 65 hits inhibiting the MK2–OCT4 interaction. Using these observations, we present here a novel cell‐based luminescence assay to identify compounds that inhibit the interaction between these kinases and OCT4. To find a druggable target to modulate c‐MYC activity in cancer, we identified two kinases, MAPKAPK2 (MK2) and the DNA‐dependent protein kinase catalytic subunit (DNA‐PKcs), which phosphorylate the Ser111 and the Ser93 residues of OCT4, respectively, to transcriptionally activate c‐MYC. Targeting c‐MYC activity has therapeutic potential, but efforts thus far have been mostly unsuccessful. Amplification‐independent c‐MYC overexpression is suggested in multiple cancers.
0 Comments
Leave a Reply. |